[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
March 6, 2018

Do All Patients Need β-Blockers After a Heart Attack?

JAMA. 2018;319(9):853-855. doi:10.1001/jama.2018.0107

Two large observational studies published last year in the Journal of the American College of Cardiology (JACC) are raising questions about the need for β-blockers in all patients after a first heart attack. Both found a limited mortality benefit associated with use of β-blockers in certain clinical scenarios, underscoring the need for randomized clinical trials (RCTs) designed to test the effectiveness of these historical drugs in the contemporary era, the researchers said.